News Center

• Mar. 13

  2023

  NMPA ACCEPTANCE OF APPLICATION FOR MARKETING APPROVAL OF ENLONSTOBART FOR INJECTION

• Mar. 11

  2023

  FIRST PATIENT DOSED IN PHASE III CLINICAL TRIAL OF DUOENDA (多恩達®) (MITOXANTRONE HYDROCHLORIDE LIPOSOME INJECTION) FOR THE TREATMENT OF RECURRENT METASTATIC NASO

• Mar. 02

  2023

  NBL-020 FOR THE TREATMENT OF ADVANCED SOLID TUMORS OBTAINS CLINIAL TRIAL APPROVAL IN CHINA

• Jan. 19

  2023

  Octreotide Long-Acting Injection Obtains Clinical Trial Approval

• Jan. 09

  2023

  levidipine Injectable Emulsion Obtains Clinical Approval

• Jan. 05

  2023

  Meloxicam Nanocrystal Injection Obtains Clinical Trial Approval